http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2006133902-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2095 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2059 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2077 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-085 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1623 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1635 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1652 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-075 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1694 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-075 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-085 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14 |
| filingDate | 2005-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2008-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2006133902-A |
| titleOfInvention | SOLID PREPARATION FORMS OF OSPEMIFEN |
| abstract | 1. A solid dosage form comprising granular materials containing a therapeutically active compound of formula (I) or its geometric isomer, stereoisomer, pharmaceutically acceptable salt, ester or metabolite, in combination with one or more intragranular excipients. 2. The dosage form according to claim 1, wherein compound (I) is ospemifene. The dosage form according to claim 1, wherein the at least one intragranular excipient is a disintegrant. The dosage form of claim 1, wherein the at least one intragranular excipient is a diluent. The dosage form according to claim 1, wherein the at least one intragranular excipient is a binding agent. The dosage form of claim 1, wherein the intragranular excipient is a combination of at least one diluent and at least one binding agent; a combination of at least one diluent and at least one disintegrant; a combination of at least one baking powder and at least one binding agent; or a combination of at least one diluent, at least one disintegrant and at least one binding agent. The dosage form according to claim 3, wherein the baking powder is selected from the group consisting of povidone, crospovidone, carboxymethyl cellulose, methyl cellulose, alginic acid, croscarmellose sodium, sodium starch glycolate, starch, formaldehyde-casein, or combinations thereof. The dosage form according to claim 4, wherein |
| priorityDate | 2004-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 79.